Composition of cabazitaxel and sulfobutylether beta-cyclodextrin
摘要
The present invention is directed to a composition comprising (a) cabazitaxel and (b) sulfobutyl ether beta cyclodextrin. Such composition exhibits unexpectedly desirable stability in aqueous media, permitting therapeutic dosages of the drug to be administered without the use of either ethanol or surfactants.
申请公布号
AU2013377404(A1)
申请公布日期
2015.07.30
申请号
AU20130377404
申请日期
2013.12.23
申请人
PIETRZYNSKI, GRZEGORZ;PATEL, KISHORE;ALAKHOV, VALERY;SUPRATEK PHARMA, INC.